Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy shows promise in delaying prostate cancer relapse

NCT ID NCT02274779

First seen Feb 17, 2026 · Last updated May 19, 2026 · Updated 13 times

Summary

This study looked at 74 men with prostate cancer that had come back in up to 5 pelvic lymph nodes after initial treatment. They received high-dose radiation to those spots plus hormone therapy. The goal was to see if this approach could delay the cancer from growing again. The main result was the average time before a relapse occurred.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • ICO Paul Papin

    Angers, France

  • ICO René Gauducheau

    Saint-Herblain, 44800, France

Conditions

Explore the condition pages connected to this study.